Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Schalk, Enrico  [Clear All Filters]
2023
Teschner D, Berisha M, Panse J, Schmitt T, Fiegle E, Naendrup J-H, Neitz J, Schmidt-Hieber M, Hentrich M, Böll B, et al. Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis. Eur J Haematol. 2023.
Hentrich M, Böll B, Teschner D, Panse J, Schmitt T, Naendrup J-H, Schmidt-Hieber M, Neitz J, Fiegle E, Schalk E. Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry. Infection. 2023.
Schalk E, Panse J. Which trial do we need? Scheduled central venous catheter (CVC) removal vs. routine clinical care for prevention of CVC-related bloodstream infections in patients with haematological malignancies. Clin Microbiol Infect. 2023.
2022
Giesen N, Busch E, Schalk E, Beutel G, Rüthrich MM, Hentrich M, Hertenstein B, Hirsch HH, Karthaus M, Khodamoradi Y, et al. AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants. Eur J Cancer. 2022;181:102-118.
2021
Giesen N, Sprute R, Rüthrich M, Khodamoradi Y, Mellinghoff SC, Beutel G, Lueck C, Koldehoff M, Hentrich M, Sandherr M, et al. 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy. Eur J Cancer. 2021;147:154-160.